CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 150 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2014. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $56,000 | -43.4% | 23,846 | -30.9% | 0.00% | – |
| Q4 2017 | $99,000 | +15.1% | 34,525 | +15.8% | 0.00% | – |
| Q3 2017 | $86,000 | +16.2% | 29,805 | 0.0% | 0.00% | – |
| Q2 2017 | $74,000 | -19.6% | 29,805 | +17.6% | 0.00% | – |
| Q1 2017 | $92,000 | -22.0% | 25,351 | -23.9% | 0.00% | – |
| Q4 2016 | $118,000 | +22.9% | 33,302 | +35.1% | 0.00% | – |
| Q3 2016 | $96,000 | -11.1% | 24,657 | 0.0% | 0.00% | – |
| Q2 2016 | $108,000 | +17.4% | 24,657 | 0.0% | 0.00% | – |
| Q1 2016 | $92,000 | -73.8% | 24,657 | +11.0% | 0.00% | – |
| Q4 2015 | $351,000 | +80.0% | 22,214 | +21.9% | 0.00% | – |
| Q3 2015 | $195,000 | -56.8% | 18,230 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $451,000 | -5.5% | 18,230 | +7.2% | 0.00% | 0.0% |
| Q1 2015 | $477,000 | +84.9% | 17,012 | +23.1% | 0.00% | – |
| Q4 2014 | $258,000 | +34.4% | 13,819 | -3.5% | 0.00% | – |
| Q3 2014 | $192,000 | – | 14,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 844,981 | $15,421,000 | 7.11% |
| DOHENY ASSET MANAGEMENT /CA | 195,345 | $3,565,000 | 1.70% |
| First Light Asset Management, LLC | 153,617 | $2,804,000 | 1.59% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,194,000 | 0.93% |
| Iguana Healthcare Management, LLC | 100,000 | $1,825,000 | 0.88% |
| Eventide Asset Management | 288,700 | $5,269,000 | 0.58% |
| Bedell Frazier Investment Counselling, LLC | 60,820 | $1,110,000 | 0.54% |
| STONERIDGE INVESTMENT PARTNERS LLC | 214,327 | $3,911,000 | 0.52% |
| Fernwood Investment Management, LLC | 31,350 | $572,000 | 0.49% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 168,560 | $3,076,000 | 0.37% |